相关实验视频
Updated: Jul 16, 2025

07:58
Characterizing Mutational Load and Clonal Composition of Human Blood
Published on: July 11, 2019
7.4K
不同类型的克隆性血液形成的共同和独特的遗传病因
Derek W Brown1,2, Liam D Cato3,4, Yajie Zhao5
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Nature communications
|September 8, 2023
概括
克隆性血液形成 (CH) 可以表现为各种形式,包括基因突变 (CHIP) 和染色体变异 (mCA). 这项研究揭示了CH类型之间的共同遗传联系和进化权衡,影响恶性瘤风险.
科学领域:
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
- 基因组学就是基因组学.
- 癌症研究 癌症研究
背景情况:
- 克隆性造血 (CH) 涉及与年龄相关的突变造血干细胞的扩张.
- 冠状病毒呈现多种类型,包括CHIP (基因突变),mCA (染色体变异) 和性染色体损失 (LOY).
- 不同的CH类型的同时发生和相互作用仍然不完全理解.
研究的目的:
- 研究不同类型的克隆性血液形成的共同遗传结构.
- 探索不同CH亚型的进化动态和共发生模式.
- 评估同时发生的CH对血液恶性瘤风险的影响,并确定与白血病相关的新型遗传位置.
主要方法:
- 整合了来自最多482,378名英国生物库参与者的全基因组测序和基因型阵列数据.
- 对CHIP,mCA和LOY的遗传架构,共发生模式和细胞健康状况的分析.
- 利用共同的遗传因素来识别与白血病风险相关的新发位点.
主要成果:
- 证明了不同类型的克隆性血液形成的基础是共享的遗传结构.
- 确定了细胞进化权衡,在CHIP突变的个体中,性染色体损失 (LOY) 的比率较低.
- 观察到CHIP和mCA的同时发生,特别是涉及TET2,DNMT3A和JAK2,CHIP通常会在mCA收购之前发生.
- 发现,具有重叠性CH的个体在未来患有淋巴细胞和骨髓细胞恶性瘤的风险显著增加.
- 通过利用CH特征的共享遗传结构,确定了15个与白血病风险相关的新型遗传位置.
结论:
- 克隆性血液形成亚型具有共同的基因架构,并表现出复杂的进化相互作用.
- 同时发生的CH,特别是涉及特定的基因突变和染色体变异,显著提高了血液恶性瘤的风险.
- 该研究确定了导致白血病风险的新型遗传基因位点,进步了我们对血液癌症发展的理解.
相关概念视频
Hematopoiesis
5.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.4K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Production of Formed Elements
1.5K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.5K
Overview of Hematopoiesis
4.1K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.1K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K

